AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2013
May 8, 2013
35124_dirs_2013-05-08_c2d314c7-b7f9-4be3-815c-803ebdc3fa4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2013-05-06
Reporting Person: LINK MAX (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-06 | Option to Purchase Celsion Corporation Common Stock | $0.97 | A | 45000 | Acquired | 2023-05-06 | Celsion Corporation Common Stock (45000) | Direct |
Footnotes
F1: The option vests in thirds on May 6, 2013, May 6, 2014 and May 6, 2015.
F2: Represents the closing price of Celsion Corporation Common Stock on the date of grant.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18